5Gono AM. Risk faclor modification: rationale for management of dyslipidemia[ J]. Am J Med,1998,104(2A) :6.
6Bhopal R, Unwin N, White M, et al. Heterogeneity of coronary heart disease risk factors in Indian, Pskistani, Bangladeshi and European orgin populations : cross sectional study[ J]. BMJ, 1999,319 (7204) :215.
7Corti MC, Lloyd GW, Alpaslan M, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons[ J]. Intem Med, 1997,126 (3) :753-760.
8Watts GF, Lewis B, Brunt JN, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomsas' Atherosclerosis Regression Study(STARS) [ J]. Lancet, 1992,339 ( 8793 ) : 563-569.
9Topping DI. Metabolic efects of carbonmonoxide in relation to athemgenesis [ J ]. Ather Osclerosis, 1977,26 (2) : 129-137.
10Moghadasiam MH, Mancini GB, Frohlich JJ. Pharmaeotherapy of hypereholesterolaemia: statin in clinical practice [ J ]. Expert Opin Pharmaeother, 2000,1 (4) :683 -695.
